Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer

Clinical trial NCT00678392 · COMPLETED

Trial details

NCT number: NCT00678392
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Kidney Neoplasms

Start date: 2008-09-03
Primary completion: 2010-08-31
Enrollment: 723

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.